Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Synthetic peptides for AIDS research.

Carlo Di Bello1, Antonella Pasquato, Monica Dettin

  • 1Department of Chemical Process Engineering, via Marzolo, 9, University of Padova, 35131 Padova, Italy. carlo.dibello@unipol.it

Current Protein & Peptide Science
|August 24, 2004
PubMed
Summary

Synthetic peptides targeting human immunodeficiency virus (HIV) entry mechanisms offer potential for developing new anti-HIV drugs. Research explores peptide interactions with viral proteins like gp120 and coreceptors for rational drug design.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gold Nanorod-Radiopharmaceutical Conjugates for Nuclear Medicine Theranostics: A Methodological and Multiscale Perspective.

International journal of molecular sciences·2026
Same author

Peptide-Functionalized Gold Nanorods as a Model to Reach the Cell Nucleus: Synthesis and Structural Characterizations in View of Theragnostic Applications.

The journal of physical chemistry. B·2026
Same author

Towards better understanding of assimilate transfer and phloem loading in conifer trees.

Journal of experimental botany·2026
Same author

Optimizing non-crosslinked type I collagen barrier membranes for guided bone regeneration: a comparative study of a BMP-2 derived peptide adsorption and covalent grafting.

Biomedical materials (Bristol, England)·2026
Same author

Protease profiling in fecal samples: a novel non-invasive diagnostic tool for gastrointestinal disorders.

Scientific reports·2025
Same author

Identification and Characterization of a Small-Molecule Inhibitor of the <i>Pseudomonas aeruginosa</i> SOS Response.

ACS infectious diseases·2025

Area of Science:

  • Virology and Molecular Biology
  • Drug Discovery and Development

Background:

  • Acquired immunodeficiency syndrome (AIDS), caused by human immunodeficiency virus type 1 (HIV-1), remains a critical global health challenge despite existing chemotherapies.
  • HIV-1 infection involves a crucial step: the formation of a complex between viral surface proteins (gp120) and host cell receptors (CD4, CCR5/CXCR4).
  • Understanding these molecular interactions is key to developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of the gp120 V3 loop in CD4 binding during HIV-1 infection.
  • To elucidate the significance of the N-terminal sequence of the HIV CCR5 coreceptor in viral entry.
  • To explore the potential of peptide sequences mimicking the CXCR4 natural ligand (SDF-1) for anti-HIV activity.
  • To determine the influence of secondary structure on the enzymatic processing of gp160 into gp120.

Related Experiment Videos

Main Methods:

  • Utilized synthetic peptides that mimic reduced sequences of key viral and host cell surface proteins.
  • Studied the binding interactions between viral proteins (gp120) and host cell receptors (CD4, CCR5, CXCR4).
  • Investigated the structural requirements of peptides for anti-HIV activity and their potential as drug leads.

Main Results:

  • Demonstrated the critical role of the gp120 V3 loop in mediating CD4 binding.
  • Highlighted the importance of specific N-terminal sequences in the HIV CCR5 coreceptor for viral entry.
  • Identified peptide sequences with potential inhibitory properties by mimicking the natural ligand of CXCR4 (SDF-1).
  • Showcased the influence of secondary structure on the processing of gp160 to gp120.

Conclusions:

  • Short peptides with minimal structural requirements exhibit significant anti-HIV activity, presenting promising lead compounds for rational drug design.
  • Targeting the interactions between viral envelope proteins and host cell receptors using peptide-based therapeutics is a viable strategy against HIV-1.
  • Further research into peptide structure-activity relationships can accelerate the development of novel anti-AIDS agents.